0,971  0,002  Antipsoriatic
0,955  0,003  Antiosteoporotic
0,952  0,002  Bone diseases treatment
0,949  0,003  Carcinogenic
0,937  0,000  Hyperparathyroidism treatment
0,935  0,001  Antiparkinsonian, rigidity relieving
0,935  0,004  Transcription factor NF kappa B inhibitor
0,917  0,003  CYP3A4 substrate
0,913  0,003  Chemopreventive
0,912  0,002  Proliferative diseases treatment
0,908  0,004  Teratogen
0,900  0,005  Antiinflammatory
0,899  0,004  Embryotoxic
0,892  0,004  Immunomodulator
0,884  0,004  TNF expression inhibitor
0,870  0,009  Apoptosis agonist
0,792  0,006  Antileukemic
0,781  0,006  Respiratory analeptic
0,776  0,007  Antihypercholesterolemic
0,764  0,006  Chemoprotective
0,738  0,003  Antidiabetic (type 1)
0,713  0,001  Paget's disease treatment
0,727  0,017  Antineoplastic (breast cancer)
0,705  0,008  Cholesterol antagonist
0,699  0,003  Antipruritic, allergic
0,695  0,000  Vitamin D receptor agonist
0,688  0,005  Antineoplastic enhancer
0,675  0,006  Immunosuppressant
0,670  0,004  Hair growth stimulant
0,664  0,007  Nitric oxide antagonist
0,658  0,003  Antiacne
0,642  0,002  Interferon gamma antagonist
0,642  0,004  Interleukin agonist
0,643  0,012  Sensitization
0,638  0,008  Hepatic disorders treatment
0,635  0,011  Analeptic
0,629  0,016  Antineoplastic (solid tumors)
0,617  0,010  NOS3 expression inhibitor
0,598  0,011  Antineoplastic (pancreatic cancer)
0,594  0,019  Prostate cancer treatment
0,575  0,001  Vitamin D receptor antagonist
0,565  0,001  Hypercalcemia treatment
0,560  0,001  Parathyroid hormone antagonist
0,575  0,016  Radioprotector
0,561  0,004  Bone formation stimulant
0,566  0,013  Caspase 3 stimulant
0,559  0,014  Lipoprotein disorders treatment
0,535  0,001  CYP24 inhibitor
0,531  0,002  Antipruritic, non-allergic
0,530  0,005  Contraceptive
0,542  0,019  Cytotoxic
0,521  0,000  Vitamin D-like
0,520  0,010  Renal disease treatment
0,533  0,040  Antineoplastic (lung cancer)
0,496  0,005  Prostate disorders treatment
0,498  0,013  Antineoplastic (lymphoma)
0,488  0,007  Prostatic (benign) hyperplasia treatment
0,490  0,013  Hypolipemic
0,499  0,022  Antifungal
0,495  0,019  Antineoplastic (glioma)
0,482  0,006  Calcium channel activator
0,472  0,005  Sodium/bile acid cotransporter inhibitor
0,466  0,004  Androgen antagonist
0,469  0,007  Abortion inducer
0,475  0,015  UGT2B4 substrate
0,469  0,013  Antineoplastic (liver cancer)
0,465  0,014  UDP-glucuronosyltransferase substrate
0,465  0,022  NOS2 expression inhibitor
0,447  0,005  Interleukin 4 antagonist
0,463  0,025  Antineoplastic (brain cancer)
0,468  0,032  Antineoplastic (ovarian cancer)
0,482  0,046  Antibacterial
0,437  0,003  Pregnane X receptor agonist
0,440  0,010  Non-steroidal antiinflammatory agent
0,429  0,009  UGT2B7 substrate
0,439  0,022  Antineoplastic (glioblastoma multiforme)
0,400  0,003  Actinic keratosis treatment
0,415  0,023  Antiparasitic
0,437  0,046  Antineoplastic (colorectal cancer)
0,395  0,006  Acute respiratory distress syndrome (ARDS) treatment
0,453  0,065  Cyclophilin D inhibitor
0,453  0,065  Antidiabetic
0,419  0,032  Antioxidant
0,395  0,011  Antiviral (Influenza)
0,398  0,015  UGT1A4 substrate
0,386  0,004  Farnesoid X receptor antagonist
0,394  0,014  Hepatoprotectant
0,399  0,024  Antineoplastic (renal cancer)
0,413  0,046  Immunostimulant
0,395  0,028  Tumour necrosis factor alpha release inhibitor
0,373  0,007  DNA polymerase I inhibitor
0,366  0,009  Antiviral (Influenza A)
0,411  0,059  Antineoplastic (myeloid leukemia)
0,356  0,005  Neurotrophic factor
0,388  0,042  Apoptosis antagonist
0,354  0,010  Liver fibrosis treatment
0,329  0,003  CDC25A inhibitor
0,372  0,052  ICAM1 expression inhibitor
0,329  0,009  Cholesterol synthesis inhibitor
0,364  0,051  AR expression inhibitor
0,315  0,014  CYP2B6 inhibitor
0,351  0,053  Antineoplastic (melanoma)
0,354  0,060  Antineoplastic (colon cancer)
0,306  0,020  Lipocortins synthesis antagonist
0,306  0,030  Antihelmintic
0,338  0,065  Antihypertensive
0,389  0,117  Caspase 9 stimulant
0,290  0,021  Skin whitener
0,271  0,014  Antifungal enhancer
0,317  0,060  CYP2C19 substrate
0,256  0,005  Keratolytic
0,297  0,045  Antineoplastic (bladder cancer)
0,284  0,036  UGT1A1 substrate
0,255  0,007  Microtubule formation inhibitor
0,255  0,014  Antineoplastic antibiotic
0,262  0,027  Skin irritative effect
0,285  0,055  Angiogenesis stimulant
0,255  0,028  Anesthetic
0,245  0,022  UGT2B9 substrate
0,295  0,077  Interleukin 2 agonist
0,219  0,004  5-Alpha-reductase inhibitor
0,226  0,012  Choleretic
0,290  0,078  Metabolic disease treatment
0,214  0,008  ABCA1 expression enhancer
0,211  0,007  Inducible nitric-oxide synthase inhibitor
0,256  0,052  Mutagenic
0,291  0,088  Antineoplastic (endocrine cancer)
0,198  0,004  Anabolic
0,299  0,107  CYP2C9 substrate
0,266  0,080  Antidiabetic (type 2)
0,217  0,036  Protein kinase stimulant
0,201  0,021  Antieczematic
0,323  0,146  Alzheimer's disease treatment
0,201  0,029  Protein-tyrosine phosphatase 1B inhibitor
0,201  0,032  Arachidonic acid antagonist
0,187  0,019  Alcohol dehydrogenase substrate
0,210  0,043  Protein-tyrosine phosphatase inhibitor
0,169  0,005  Anticholelithogenic
0,175  0,011  Interleukin 2 antagonist
0,231  0,069  Interleukin antagonist
0,163  0,004  Na+ K+ transporting ATPase inhibitor
0,163  0,011  UGT2B11 substrate
0,199  0,047  Urolithiasis treatment
0,152  0,007  Bile acid receptor antagonist
0,167  0,023  Contraceptive female
0,189  0,047  UGT2B10 substrate
0,189  0,050  Antineoplastic (bone cancer)
0,147  0,010  T cell inhibitor
0,273  0,136  Antiobesity
0,225  0,091  Antineoplastic (non-small cell lung cancer)
0,137  0,004  Liver X receptor alpha agonist
0,194  0,062  Diabetic nephropathy treatment
0,156  0,024  Antiinfertility, female
0,149  0,019  Antibiotic
0,207  0,079  Antihypertriglyceridemic
0,211  0,084  UGT1A6 substrate
0,217  0,091  Antineoplastic (cervical cancer)
0,191  0,067  Antiviral (Hepatitis)
0,139  0,019  SULT1E1 substrate
0,124  0,005  Liver X receptor agonist
0,174  0,058  Diuretic
0,156  0,044  Antihyperlipoproteinemic
0,142  0,032  Sulfotransferase substrate
0,175  0,066  UGT1A3 substrate
0,224  0,119  Antineoplastic (multiple myeloma)
0,139  0,034  UGT2B1 substrate
0,169  0,066  Antiviral (Hepatitis C)
0,207  0,104  Vascular (periferal) disease treatment
0,153  0,057  Adenylate cyclase stimulant
0,105  0,009  Progesterone antagonist
0,142  0,047  Vanilloid 1 agonist
0,158  0,063  UGT2B15 substrate
0,228  0,134  CTGF expression inhibitor
0,178  0,088  Anesthetic general
0,155  0,067  NOS3 expression enhancer
0,111  0,023  Vanilloid agonist
0,204  0,116  DNA synthesis inhibitor
0,158  0,076  Uterine stimulant
0,155  0,075  Antiviral (Herpes)
0,246  0,168  Atherosclerosis treatment
0,097  0,023  Glycine receptor agonist
0,187  0,113  Cytostatic
0,084  0,011  Postcoital contraceptive
0,137  0,068  Interleukin 1 antagonist
0,139  0,070  Amylase inhibitor
0,128  0,060  Growth stimulant
0,141  0,073  Antifungal (Cryptococcus)
0,094  0,030  SULT1A2 substrate
0,071  0,009  RNA-directed RNA polymerase stimulant
0,077  0,018  Heme oxygenase stimulant
0,075  0,017  Lipocortins synthesis agonist
0,078  0,020  Protein 50S ribosomal subunit inhibitor
0,061  0,005  HMG CoA reductase inhibitor
0,155  0,103  LDLR expression enhancer
0,061  0,009  Farnesoid X receptor agonist
0,175  0,124  VCAM1 expression inhibitor
0,062  0,012  Microtubule stabilization
0,078  0,030  CDC25B inhibitor
0,074  0,028  Androgen agonist
0,046  0,007  5-Alpha-reductase 2 inhibitor
0,049  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,096  0,060  Interleukin 12 antagonist
0,047  0,013  Cholesterol absorption inhibitor
0,107  0,074  Interleukin 1b antagonist
0,139  0,107  Antipruritic
0,135  0,105  Melanin inhibitor
0,145  0,116  Phospholipase C inhibitor
0,156  0,128  Growth factor agonist
0,035  0,007  Hedgehog signaling activator
0,086  0,058  Transcription factor NF kappa B stimulant
0,157  0,129  Transplant rejection treatment
0,035  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,041  0,019  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,039  0,017  Tubulin agonist
0,152  0,132  Antiulcerative
0,056  0,036  Postmenopausal disorders treatment
0,053  0,034  Estrogen agonist
0,031  0,012  1,3-Beta-glucan synthase inhibitor
0,082  0,065  Ornithine decarboxylase inhibitor
0,029  0,014  Retinoid X gamma receptor antagonist
0,164  0,150  Spasmolytic
0,090  0,077  Nitric-oxide synthase inhibitor
0,103  0,091  Estrogen antagonist
0,022  0,010  Progesterone receptor B antagonist
0,092  0,082  Monophenol monooxygenase inhibitor
0,072  0,064  Antitreponemal
0,014  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,076  0,071  Antineoplastic alkaloid
0,020  0,016  Corticosteroid-like
0,016  0,013  5-Alpha-reductase 1 inhibitor
0,020  0,016  Retinoid X beta receptor antagonist
0,030  0,027  Estrogen receptor alpha agonist
0,138  0,135  P-glycoprotein inhibitor
0,148  0,146  Antineoplastic (lymphocytic leukemia)
0,148  0,147  Free radical scavenger

